Dexter X. Jin

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer

Alexa B. Schrock, Ching Ouyang, Jaideep Sandhu et al. · Annals of Oncology · 2019 · 628 citations

Medicine, Immunology, Oncology +17

Epithelial-to-Mesenchymal Transition Activates PERK–eIF2α and Sensitizes Cells to Endoplasmic Reticulum Stress

Yuxiong Feng, Ethan S. Sokol, Catherine Del Vecchio Fitz et al. · Cancer Discovery · 2014 · 327 citations

Life Sciences, Cancer Biology, Cell Biology +17

Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response

Meagan Montesion, Karthikeyan Murugesan, Dexter X. Jin et al. · Cancer Discovery · 2020 · 248 citations · Full text

Medicine, Immunology, Oncology +17

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population

C. Benedikt Westphalen, Matthew Krebs, C. Le Tourneau et al. · npj Precision Oncology · 2021 · 200 citations · Full text

Medicine, Genetics, Oncology +17

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

Mrinal M. Gounder, Narasimhan P. Agaram, Sally E. Trabucco et al. · Nature Communications · 2022 · 193 citations · Full text

Medicine, Genetics, Oncology +17